Dr. Roscoe F. Morton
Dr. Morton joined Drs. Buroker and Shreck in June 1981 in the newly formed group Medical Oncology and Hematology Associates. Dr. Morton’s undergraduate work was completed in 1972 at the Colorado College in Colorado Springs where he received a B.A. degree in Biology. His M.D. was awarded 1976 with honors by University of Kansas School of Medicine where he was also elected to the Alpha Omega Alpha Honor Medical Society. Dr. Morton completed a residency in Internal Medicine at the University of Kansas School of Medicine Wichita Campus in 1979 and a fellowship in Medical Oncology in 1981 at the Mayo Graduate School of Medicine in Rochester.
Board-certified: Internal medicine; medical oncology
Residency: University of Kansas School of Medicine Wichita Campus
Fellowship: Mayo Graduate School of Medicine in Rochester
Certification: Dr. Morton is certified by the American Board of Internal Medicine in both Internal Medicine and Medical Oncology and by the American Academy of Hospice and Palliative Medicine.
Professional Interests: Chair of the Clinical Practice Committee at the American Society of Clinical Oncology, Member of the Government Relations Committee, Member of the Ethics Committee, Chair of the Constitution and Bylaws Committee Alliance for Clinical Trials in Oncology, Chair of the Executive Committee at the North Central Cancer Treatment Group, Principal Investigator Iowa Oncology Research Association NCI-CCOP, Chair of the Constitution and Bylaws Committee North Central Cancer Treatment Group, Member of the National Cancer Institute’s Task Force on Colon Cancer, Member of the National Cancer Institute’s Gastrointestinal Cancer Steering Committee, President Iowa Oncology Society, Fellow of the American College of Physicians
Publications: Dr. Morton has published over 50 research articles and 25 abstracts as an investigator for the North Central Cancer Treatment Group (NCCTG) that is a cancer research outreach program of the Mayo Clinic Comprehensive Cancer Center. Most of his publications focus on colon and rectal cancer, breast cancer, lung cancer, and melanoma.